An interventional study of Prehabilitation in Gastric Cancer, sponsored by National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos. Active, not recruiting at 2 sites in Lithuania. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2023-11-08.
Sponsored by National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 12 studies in Stomach Neoplasms with a site in Lithuania — 1 open to participants now, 2 under way, 1 of them phase 3. Stomach Neoplasms · Lithuania.
Among the 12 studies in Stomach Neoplasms with a site in Lithuania, this one is the only one that started in 2020, is one of 2 with no phase, and was the 8th registered.
3,404 studies on the registry are indexed under Stomach Neoplasms; 996 are open to participants now.
Browse Stomach Neoplasms studies →1 of the 12 studies in Stomach Neoplasms with a site in Lithuania is open now. Recruiting first, the newest first:
Ukrainian Society of Clinical Oncology · Sites in Lithuania, Ukraine
Ages 18–80
A study can be open while its sites in Lithuania have not opened yet or have stopped. Only those recruiting at a site in Lithuania →
Of the 705 Stomach Neoplasms studies recruiting now, 377 (53%) set no upper age limit and 194 (28%) stop at 75 or younger; 28 take children under 18; 70 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
12 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 2 2 · Phase 3 7
First in 2010; this study’s year is marked. 1 started in 2020.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 128 is above the median of 66 across 2,503 interventional studies indexed under Stomach Neoplasms.
Median enrollment 547 across the 9 interventional studies, 1,000 across the 3 observational. Of the 10 that completed or were terminated, 3 (30%) have results posted.
This tab as a report to print or save as PDF → With an account.
5 of 12 have an industry lead sponsor. The 10 most frequent:
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos is the lead sponsor of 9 studies on the registry; 5 are open to participants now.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos has 1 study filed under Stomach Neoplasms — fewer than ten, so there is no comparison to draw.
1 of the studies in Stomach Neoplasms with a site in Lithuania that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT06028737Phase 3Ukrainian Society of Clinical OncologyTotal Neoadjuvant FLOT Chemotherapy in Locally Advanced Gastric and Gastroesophageal Junction Cancer | 2027-04-25 |
Add it to your calendar (.ics) → With an account.
Among the 12 studies in Stomach Neoplasms with a site in Lithuania, from their registry updates:
Nothing recorded among them since 2026-09-25.
This tab as a report to print or save as PDF → With an account.
Prehabilitation has been demonstrated to be an effective strategy to improve outcomes in patients undergoing some of the abdominal operations. It may increase the physical capacity of the patient, improve postoperative quality of life and even decrease the postoperative morbidity. Currently, the most effective strategy seems to be a trimodal prehabilitation which includes: 1) Nutritional support 2) Psychological support and 3) Physical training.
This study will investigate personalized trimodal prehabilitation for patients undergoing gastrectomy for gastric cancer.
Prehabilitation group:
Patients will undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a grip strength test, a timed Up \& Go (TUG) test, 10 m sprint test and sit to stand test before and after prehabilitation. The trimodal intervention will involve:
Psychological intervention: Patients will undergo consultation by specialized onco-psychologist. The anxiety and depression level will be evaluated by HAD score and patients will be trained to perform techniques, such as relaxation to reduce and manage anxiety on at home basis.
The psychologist also will enhance patients' motivation to comply with the exercise and nutritional aspects of the intervention.
All patients will be routinely contacted to ensure compliance with prehabilitation program.
Patients scheduled for surgery first by multidisciplinary tumor board will undergo 4 weeks prehabilitation program, while patients scheduled for perioperative chemotherapy will undergo prehabilitation while neoadjuvant treatment will be administered.
Control group:
Patients will also undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a grip strength test, a timed Up \& Go (TUG) test, 10 m sprint test and sit to stand test before surgery or before and after neoadjuvant chemotherapy. Patients will not undergo prehabilitation.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Patients in the experimental group will undergo prehabilitation before the elective surgery for gastric cancer.
Other: Prehabilitation
Patients in the control group will not undergo prehabilitation.
Patients will undergo 6 Minutes Walking Test (6-MWT), spiroergometry (VO2 max; AT), a grip strength test, a timed Up \& Go (TUG) test, 10 m sprint test and sit to stand test before and after prehabilitation. The trimodal intervention will involve: 1. Nutritional intervention 2. Psychological intervention 3. Exercise intervention
Postoperative morbidity rate by Clavien-Dindo
Time frame: At 90 days postoperatively
Physical status by Spiroergometry
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Physical status by International Physical Activity Questionnaire (IPAQ)
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Postoperative mortality rate
Time frame: At 30 and 90 days postoperatively
Nutritional status by albumin level
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Quality of Life by EORTC questionnaires
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Percentage of patients reaching the complete oncological treatment fixed in a multidisciplinary tumour board (including preoperative chemotherapy, surgery and postoperative chemotherapy)
Time frame: 12 months after surgery
Physical status by grip strength test
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Physical status by 6 minutes walk test
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Physical status by the sit to stand test
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Physical status by the timed up&go test
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Psychological status by Hospital Anxiety and Depression Scale (HADS).
Time frame: Baseline, pre-surgery, 3, 6 and 12 months after surgery
Plan to share: Undecided
Ran from Feb 2020 to primary completion in Oct 2023, 43 months.
Of 357 non-industry interventional studies with no phase under Stomach Neoplasms, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 17 and three quarters within 66. This study's 43 months is above that.
Counting every sponsor, half of 368 studies reached it within 36 months; a quarter within 17 and three quarters within 63.
How these figures are worked out, and which studies are left out of them.
This study is active, not recruiting, as verified in Nov 2023. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos